Common high blood pressure meds may lower colorectal cancer risk

By ÃÛÑ¿´«Ã½ News

Hiroshi Watanabe/Stone, Getty Images
(Hiroshi Watanabe/Stone, Getty Images)

Medications commonly prescribed to treat high blood pressure also could reduce the risk of colorectal cancer, according to a new study.

Researchers reviewed health records of 187,897 adults in Hong Kong from 2005 to 2013. Those who took medicines that block angiotensin, a chemical that causes arteries to narrow, had a 22% lower risk of developing colorectal cancer in the subsequent three years.

The drugs angiotensin converting enzyme inhibitor and angiotensin II receptor blocker – ACE-i and ARB, for short – are prescribed for conditions such as heart failure and heart disease. Doctors also commonly prescribe them to people with high blood pressure to relax and open blood vessels, thereby lowering blood pressure.

The study was published Monday in the ÃÛÑ¿´«Ã½ journal . It is the first to show the medicines' potential protective effect on the development of colorectal cancer, study author Dr. Wai K. Leung said in a news release.

"The roles of ACE inhibitors and ARBs on cancer development are controversial and, in some cases, study findings are conflicting," said Leung, who is clinical professor of medicine at the University of Hong Kong in China. "Results of previous studies have been limited by several factors including a small number of patients and data only on short-term follow-ups. Our results provide new insights on a potential role of these medications for colorectal cancer prevention."

Colorectal cancer is the third most common cancer and the second-leading cause of cancer death worldwide.

The study also showed the benefits of ACE inhibitors and ARBs in people 55 or older and those with a history of colon polyps. The benefit was limited to the first three years.

"While ACE-i and ARBs are taken by patients with high blood pressure, heart failure and kidney diseases, the reduction in colorectal cancer risk may be an additional factor for physicians to consider when choosing anti-hypertensive medications," Leung said.

Researchers said the results should be verified in a randomized clinical trial that would actively follow patients to determine the potential benefits of these medications on colorectal cancer risk.

If you have questions or comments about this story, please email [email protected].


ÃÛÑ¿´«Ã½ News Stories

ÃÛÑ¿´«Ã½ News covers heart disease, stroke and related health issues. Not all views expressed in ÃÛÑ¿´«Ã½ News stories reflect the official position of the ÃÛÑ¿´«Ã½. Statements, conclusions, accuracy and reliability of studies published in ÃÛÑ¿´«Ã½ scientific journals or presented at ÃÛÑ¿´«Ã½ scientific meetings are solely those of the study authors and do not necessarily reflect the ÃÛÑ¿´«Ã½â€™s official guidance, policies or positions.

Copyright is owned or held by the ÃÛÑ¿´«Ã½., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to ÃÛÑ¿´«Ã½ News.

Other uses, including educational products or services sold for profit, must comply with the ÃÛÑ¿´«Ã½â€™s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.